Evaluation of the seroprevalence of influenza A(H1N1) 2009 on a university campus: a cross-sectional study
Open Access
- 13 December 2011
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 922
Abstract
Human infection with influenza A(H1N1) 2009 was first identified in the United States on 15 April 2009 and on 11 June 2009, WHO declared that the rapidly spreading swine-origin influenza virus constituted a global pandemic. We evaluated the seroprevalence of influenza A(H1N1) 2009 virus on a large public University campus, as well as disparities in demographic, symptomatic and vaccination characteristics of participants.Keywords
This publication has 26 references indexed in Scilit:
- Serologic Survey of the Pandemic H1N1 2009 Virus in Guangdong Province, China: A Cross Sectional StudyPLOS ONE, 2011
- Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic PeriodPLOS ONE, 2011
- Serological Evidence of Subclinical Transmission of the 2009 Pandemic H1N1 Influenza Virus Outside of MexicoPLOS ONE, 2011
- Pandemics and Health EquityJournal of Public Health Management & Practice, 2011
- Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) PandemicPLOS ONE, 2010
- Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USAPLOS ONE, 2010
- Public Hospital-Based Laboratory Experience during an Outbreak of Pandemic Influenza A (H1N1) Virus InfectionsJournal of Clinical Microbiology, 2010
- Public Willingness to Take a Vaccine or Drug Under Emergency Use Authorization during the 2009 H1N1 PandemicBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972